1. Volume 4, Issue 6, Pages 551-558 (December 2001)
Gene Therapy for Head and Neck Cancer Using Vaccinia Virus Expressing IL-2 in a Murine Model, with Evidence of Immune Suppression 
Hongxing Qin, Joseph Valentino, Subha Manna, Pulak K. Tripathi, Malaya Bhattacharya-Chatterjee, Kenneth A. Foon, Bert W. O'Malley, Sunil K. Chatterjee 
Molecular Therapy 
Volume 4, Issue 6, Pages (December 2001)
DOI: /mthe
Copyright © 2001 American Society for Gene Therapy Terms and Conditions

2. FIG. 1
In vivo expression of rvv-IL-2. The number of viral particles (pfu) and the amounts of IL-2 secreted in the tumors following intratumoral injection of rvv-IL-2 were determined. Each point in the graph represents the mean value obtained from three mice.
Molecular Therapy 2001 4, DOI: ( /mthe )
Copyright © 2001 American Society for Gene Therapy Terms and Conditions

3. FIG. 2
Survival of mice with oral SCC VII tumors. Each group consisted of 10 mice.
Molecular Therapy 2001 4, DOI: ( /mthe )
Copyright © 2001 American Society for Gene Therapy Terms and Conditions

4. FIG. 3
Proliferation of T cells by ConA. Proliferation of spleen, bone marrow or lymph node cells from normal mice (none), mice bearing oral SCC tumors (neck), or subcutaneous SCC tumors (skin) in the presence of ConA was determined. Radioactivity in the absence of ConA was subtracted from the corresponding values. Each group had three mice and the proliferation assay was performed separately for each mouse. Mean and SD of counts in each group are shown.
Molecular Therapy 2001 4, DOI: ( /mthe )
Copyright © 2001 American Society for Gene Therapy Terms and Conditions

5. FIG. 4
Immune suppression in mice bearing SCC tumors on various days after tumor implantation. Proliferation of spleen cells in the presence of ConA was performed as described in Materials and Methods. Inhibition of the stimulation is expressed as a percentage of the stimulation by ConA of splenocytes from age-matched mice without tumors. Each point in the graph represents the mean value obtained from three mice.
Molecular Therapy 2001 4, DOI: ( /mthe )
Copyright © 2001 American Society for Gene Therapy Terms and Conditions

6. FIG. 5
Shotgun identification of suppressor molecules involved in immune modulation. RT-PCR products were analyzed by agarose gel electrophoresis (A). The amplified DNA was transferred to nitrocellulose paper and Southern blot (B) was performed using specific oligonucleotides labeled by γ-[P32]ATP. Lane 1, RNA from tumor lesion; lane 2, RNA from cultured cells.
Molecular Therapy 2001 4, DOI: ( /mthe )
Copyright © 2001 American Society for Gene Therapy Terms and Conditions